The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Synergistic effects of RPT1G, a first-in-class small molecule NAMPT inhibitor, with venetoclax and olaparib in hematological malignancies.
 
Gregory Crimmins
Employment - Remedy Plan Therapeutics
Leadership - Remedy Plan Therapeutics
Stock and Other Ownership Interests - Remedy Plan Therapeutics
Research Funding - Remedy Plan Therapeutics
Patents, Royalties, Other Intellectual Property - WO 2019/213570; WO2021092322; WO2022241257A1
 
Min Wu
Employment - Remedy Plan Therapeutics
Stock and Other Ownership Interests - Remedy Plan Therapeutics
Research Funding - Remedy Plan Therapeutics
 
Francis Roushar
Employment - Remedy Plan Therapeutics
Stock and Other Ownership Interests - Remedy Plan Therapeutics
Research Funding - Remedy Plan Therapeutics
 
Yushma Bhurruth-Alcor
Employment - Remedy Plan Therapeutics
Stock and Other Ownership Interests - Remedy Plan Therapeutics
Research Funding - Remedy Plan Therapeutics
Patents, Royalties, Other Intellectual Property - FR EP3199534; FR WO 2019/122059; FR WO 2019/122065; FR-3079232-A1; WO 2019/213570; WO2016/102877A1; WO2021092322; WO2022241257A1
 
Timothy Jarvela
Employment - Remedy Plan Therapeutics
Stock and Other Ownership Interests - Remedy Plan Therapeutics
Research Funding - Remedy Plan Therapeutics
 
James Digel
Employment - Remedy Plan Therapeutics
Stock and Other Ownership Interests - Remedy Plan Therapeutics
Research Funding - Remedy Plan Therapeutics
 
Caroline Robb
Employment - Remedy Plan Therapeutics
Stock and Other Ownership Interests - Remedy Plan Therapeutics
Research Funding - Remedy Plan Therapeutics
Patents, Royalties, Other Intellectual Property - WO2021092322
 
Parisa Moghaddam-Taaheri
Employment - React Neuro
Stock and Other Ownership Interests - Remedy Plan Therapeutics
Research Funding - Remedy Plan Therapeutics
 
Dennise De Jesus-Diaz
Employment - Remedy Plan Therapeutics
Leadership - COO - Remedy Plan Therapeutics
Stock and Other Ownership Interests - Remedy Plan Therapeutics
Research Funding - Remedy Plan Therapeutics
Patents, Royalties, Other Intellectual Property - WO 2019/213570; WO2021092322; WO2022241257A1
 
Frank McCormick
Employment - National Cancer Institute (NCI) RAS Initiative at the Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc.
Leadership - Member of Company Board - Remedy Plan Therapeutics; Scientific Director - National Cancer Institute (NCI) RAS Initiative at the Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc.
Stock and Other Ownership Interests - BridgeBio Pharma; DNAtrix Inc.; Quartz Therapeutics
Consulting or Advisory Role - Amgen; BridgeBio Pharma; Daiichi Sankyo; DNAtrix Inc.; Exuma Biotech; Frontier Medicines; IDEAYA Biosciences; Kura Oncology; Leidos Biomedical Research; PellePharm; PMV Pharma; Quanta Therapeutics; Quartz Therapeutics; Remedy Plan Therapeutics
Research Funding - Boehringer Ingelheim; Daiichi Sankyo; Gilead Sciences